Found: 32
Select item for more details and to access through your institution.
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 571, doi. 10.1002/ajh.26826
- By:
- Publication type:
- Article
Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. 1481, doi. 10.1002/ajh.26335
- By:
- Publication type:
- Article
A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 2, p. 573, doi. 10.4143/crt.2019.542
- By:
- Publication type:
- Article
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11489-8
- By:
- Publication type:
- Article
Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2.
- Published in:
- Journal of Cancer Research & Therapeutics, 2023, v. 19, n. 6, p. 1495, doi. 10.4103/jcrt.JCRT_782_23
- By:
- Publication type:
- Article
Cancer pain management in China: current status and practice implications based on the ACHEON survey.
- Published in:
- Journal of Pain Research, 2017, v. 10, p. 1943, doi. 10.2147/JPR.S128533
- By:
- Publication type:
- Article
Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma.
- Published in:
- International Journal of Oncology, 2018, v. 52, n. 5, p. 1528, doi. 10.3892/ijo.2018.4299
- By:
- Publication type:
- Article
P-192: Circularly permuted TRAIL (CPT) combined with Thalidomide and Dexamethasone in patients with relapsed/refractory Multiple Myeloma: a randomized, double-blind, placebo-controlled phase 3 study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S143, doi. 10.1016/S2152-2650(21)02319-3
- By:
- Publication type:
- Article
P-160: Efficacy and safety of induction therapy with IAd versus IRd regimen in fragile elderly patients with newly diagnosed multiple myeloma: results of a prospective multicenter clinical trail.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S123, doi. 10.1016/S2152-2650(21)02287-4
- By:
- Publication type:
- Article
A Phase 3 Study of Carfilzomib and Dexamethasone (Kd) in Patients With Relapsed and Refractory Multiple Myeloma (MM) in China.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e267, doi. 10.1016/j.clml.2019.09.441
- By:
- Publication type:
- Article
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.15252/emmm.202114502
- By:
- Publication type:
- Article
A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01648-z
- By:
- Publication type:
- Article
Comparison of chemotherapy with or without asparaginase for extranodal nasal NK/T‐cell lymphoma in children and adolescents.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 5, p. 1, doi. 10.1002/pbc.28901
- By:
- Publication type:
- Article
Safety and feasibility analysis of rapid daratumumab infusion in Chinese patients with multiple myeloma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 11, p. 1, doi. 10.1002/cam4.7347
- By:
- Publication type:
- Article
Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 22, p. 4134, doi. 10.1002/cam4.4765
- By:
- Publication type:
- Article
The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164210
- By:
- Publication type:
- Article
A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 3, p. 422, doi. 10.1007/s12185-020-03044-z
- By:
- Publication type:
- Article
Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors.
- Published in:
- BMC Cancer, 2010, v. 10, p. 358, doi. 10.1186/1471-2407-10-358
- By:
- Publication type:
- Article
Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 1, p. 77, doi. 10.20892/j.issn.2095-3941.2022.0612
- By:
- Publication type:
- Article
Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.772015
- By:
- Publication type:
- Article
A Preliminary Study of Culture Shock and Adaptation Tactics for Overseas Chinese Students --from the Perspective of "American Dreams in China".
- Published in:
- Theory & Practice in Language Studies (TPLS), 2020, v. 10, n. 3, p. 336, doi. 10.17507/tpls.1003.11
- By:
- Publication type:
- Article
Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long-term outcomes of different bortezomibbased regimens in Chinese myeloma patients.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 587, doi. 10.2147/OTT.S97457
- By:
- Publication type:
- Article
Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 2589, doi. 10.2147/OTT.S91077
- By:
- Publication type:
- Article
Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 11, p. 2589, doi. 10.1007/s00277-020-04234-9
- By:
- Publication type:
- Article
High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 9, p. 1535, doi. 10.1007/s00277-015-2401-4
- By:
- Publication type:
- Article
New prognostic model for extranodal natural killer/T cell lymphoma, nasal type.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 9, p. 1541, doi. 10.1007/s00277-014-2089-x
- By:
- Publication type:
- Article
Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
- Published in:
- Oncology Letters, 2016, v. 12, n. 2, p. 825, doi. 10.3892/ol.2016.4691
- By:
- Publication type:
- Article